Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...

GLP-1 drugs have revolutionised the treatment of obesity, but the very reason they are effective is also why it's vital to ...

Drugs like Ozempic and Wegovy have the power to block the forces driving obesity, but the knock-on societal effects may not ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Novo Nordisk has licensed an oral obesity drug that works via an uncommon mechanism and may help patients maintain their ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

One of the lasting memories from my teenage years is what I now recognise as an obsession with weight control. Thin was in, ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related ...

The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...